Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2008
12/25/2008US20080318327 Kit and Method for Mass Labelling
12/25/2008US20080318326 Method of Manufacture
12/25/2008US20080318325 Method for the Analysis of Liposomes
12/25/2008US20080318324 Biochip for High-Throughput Screening of Circulating Tumor Cells
12/25/2008US20080318305 In situ heat induced antigen recovery and staining apparatus and method
12/25/2008US20080318277 Expression of human milk proteins in transgenic plants
12/25/2008US20080318275 Hepatitis C virus asialoglycoproteins
12/25/2008US20080318270 Measuring preferential signal from cells; obtaining cells, applying to transparent support, exposing to signaling soluton, incubating, detecting and measuring signals; masking dye absorbs excitation energy of fluorescent dye and/or emission light of fluorescent dye in second solution
12/25/2008US20080318266 Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids
12/25/2008US20080318264 Biomarkers Associated With Age-Related Macular Degeneration
12/25/2008US20080318263 bladder carcinoma prognosis via obtaining urine sample from fasted individual, centrifuging forming supernatant, recentrifuging supernatants, loading onto centrifuging filter, icing concentrates, pelletizing, resolving via SDS-PAGE and blotting to determine pro-u-plasminogen activator present
12/25/2008US20080318262 Protein Cleavage at Aspartic Acid Using Chemical Reagents
12/25/2008US20080318261 Small Volume in Vitro Analyte Sensor
12/25/2008US20080318260 Methods and Apparatus for Measuring Blood Coagulation
12/25/2008US20080318259 Hematocrit and Analyte Concentration Determination
12/25/2008US20080318257 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders; hybridoma cell line; radioimmunoassay; kits
12/25/2008US20080318256 Method for Stabilizing Coenzyme and Composition Therefor
12/25/2008US20080318255 Fluorescent Labeled Sphingosines
12/25/2008US20080318254 PSCA antibodies and hybridomas producing them
12/25/2008US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
12/25/2008US20080318252 Rapid assay to test anti-cancer drugs under physiological conditions
12/25/2008US20080318251 G protein coupled receptors for use as tools in identifying modulators of taste perception
12/25/2008US20080318250 Compositions and Methods for Identifying Sperm for Forensic Applications
12/25/2008US20080318249 Methods and reagents to increase the sensitivity of enzyme metallographic detection
12/25/2008US20080318248 Compositions and Methods of Screening Apoproteins
12/25/2008US20080318247 Biomarker for cardiac transplant rejection
12/25/2008US20080318246 Deeply quenched enzyme sensors
12/25/2008US20080318245 Alumina; phopholipid; arrays, membrane biochips, and protein biochips; affinity purification, catalysis
12/25/2008US20080318242 Methods and devices for early detection of cancer cells and types through micromechanical interactions
12/25/2008US20080318238 Method of detecting gene mutation
12/25/2008US20080318237 Methods of diagnosing endometriosis
12/25/2008US20080318236 Cell Free Screening Assay and Methods of Use
12/25/2008US20080318231 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type
12/25/2008US20080318229 Method for Diagnosing Neuro-Degenerative Disease
12/25/2008US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
12/25/2008US20080318225 Compositions and methods for detecting cancer
12/25/2008US20080318224 Large deletions in human brca1 gene and use thereof
12/25/2008US20080318221 Method for the diagnosis and/or prognosis of alzheimer's disease
12/25/2008US20080318220 Method for the diagnosis and/or prognosis of alzheimer's disease
12/25/2008US20080318216 Methods For Determining Presence of Cancer by Analyzing the Expression of Cdk9 and/or Cyclin T1 in Lymphoid Tissue
12/25/2008US20080318213 Mass Spectrometer
12/25/2008US20080318212 Orphan Receptor Tyrosine Kinase as a Target in Breast Cancer
12/25/2008US20080318211 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
12/25/2008US20080318210 Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof
12/25/2008US20080318209 Cjd Prion Testing
12/25/2008US20080318207 Sequence covariance networks, methods and uses therefor
12/25/2008US20080318203 Novel Microfluidic System and Method for Capturing Cells
12/25/2008US20080317835 Personalized Nutrient Deficiency Assay Methods
12/25/2008US20080317811 Treatment of Cancer Using Tlr3 Agonists
12/25/2008US20080317787 Anti-Malaria Vaccine
12/25/2008US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection
12/25/2008US20080317771 Anti-Clusterin Oligoclonal Antibodies for Diagnosis and Prediction of the Aggressiveness of Tumours, Diagnostic Method and Related Kits
12/25/2008US20080317764 Antibodies against 25-hydroxyvitamin d
12/25/2008US20080317758 Polypeptide variants with altered effector function
12/25/2008US20080317756 Antibodies to Chemokine Alpha-5
12/25/2008US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer
12/25/2008US20080317754 Human Osteoclast Derived Cathepsin
12/25/2008US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis
12/25/2008US20080317745 Methods of diagnosing, treating, or preventing plasma cell disorders
12/25/2008US20080317742 Biomarkers of francisella infection
12/25/2008US20080317739 Method for Treating Skeletal Disorders Resulting from Fgfr Malfunction
12/25/2008US20080317738 Mylks as Modifiers of Branching Morphogenesis and Methods of Use
12/25/2008US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor
12/25/2008US20080317733 Cosmeceutical Compositions and Methods with Biologically Active Ingredients
12/25/2008US20080317731 Phospholipases, Nucleic Acids Encoding Them and Methods for Making and Using Them
12/25/2008US20080317723 Lymphatic endothelial cells materials and methods
12/25/2008US20080317722 Methods and Compositions Involving Developmental Decision Promoter Regions
12/25/2008US20080317669 Cloning of honey bee allergen C
12/25/2008US20080317635 Testing Device For Testing Or Analysing Fluids And A Holder And A Storage Container For Such Devices
12/25/2008US20080317630 System and method for the continuous extraction of a liquid phase of microsamples, and automated installation for taking them, for carrying out the extraction and taking measurements
12/25/2008US20080317629 Analyzing device
12/25/2008US20080316480 Aggregates of plural transition metal nanoparticles and plural cyanine dye molecules
12/25/2008US20080316466 Spectroscopic Optical System
12/25/2008US20080315875 Biological detector and method
12/25/2008US20080315861 Biomolecule detector based on field effect transistor arrays containing reference electrodes and detection method for biomolecules using the same
12/25/2008US20080314882 Method of making a biosensor
12/25/2008US20080314766 Electrically-active ferromagnetic particle conductimetric biosensor test kit
12/25/2008US20080314746 Analyzer
12/25/2008US20080314745 Biosensor and its production
12/25/2008US20080314456 Fluidic Device
12/25/2008US20080314127 Sulfur in fuel tester
12/25/2008US20080314116 Breath-based sensors for non-invasive molecular detection
12/25/2008US20080314115 Compliance Apparatus
12/25/2008CA2635873A1 Method for training a user in recognition of the user's bodily fluid analyte concentration and concentration trends via user-perceived sensations
12/24/2008WO2008157834A1 Materials and methods for diagnosis of asthma
12/24/2008WO2008157785A1 T cell depleting compositions useful for treating cancer
12/24/2008WO2008157762A2 Methods to increase the photostability of dyes
12/24/2008WO2008157697A2 Copolymer assay
12/24/2008WO2008157690A2 Method and system for calculating and reporting slump in delivery vehicles
12/24/2008WO2008157689A2 Methods of nucleic acid amplification analysis
12/24/2008WO2008157584A2 Apparatus and methods for automatic insertion, debubbling, cleaning and calibration of a spectral probe during dissolution testing
12/24/2008WO2008157528A2 System and method for producing diesel exhaust for testing diesel engine aftertreatment devices
12/24/2008WO2008157518A1 Biomarkers of influenza vaccine response
12/24/2008WO2008157490A1 Synergistic treatment of cells that express epha2 and erbb2
12/24/2008WO2008157459A2 Methods and systems for identifying molecular pathway elements
12/24/2008WO2008157419A2 Immunogenic peptides of influenza virus
12/24/2008WO2008157409A1 Lyophilized immunoglobulin formulations and methods of preparation
12/24/2008WO2008157398A1 Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
12/24/2008WO2008157384A2 Method of detection of microorganisms with enhanced bacteriophage amplification
12/24/2008WO2008157383A1 Methods and compositions for diagnosis and/or prognosis of ovarian cancer and lung cancer